專家論壇

真實世界大樣本用藥人群信息化安全性評價實踐及流程規(guī)范·······················································郭代紅，賈王平，王嘯宇，寇 煒，馬 亮，陳 超，趙粟裕（3）：127

藥物評價研究及進展····························································謝婷婷，郭代紅（4）：191

臨床評價

替諾福韋酯阻斷乙型肝炎病毒母嬰傳播的療效和安全性的Meta分析···················黃 麗，龍云鑄，羅圣平，譚秋紅，劉 珂（1）：1

急性冠脈綜合征患者PCI術后CYP2C19和PON1 Q192R基因多態(tài)性與氯吡格雷抗血小板臨床療效和出血風險的相關性研究··································徐曉宇，彭文星，井浣雨，林 陽（1）：7

神經(jīng)介入術后CYP2C19基因多態(tài)性與氯吡格雷治療藥物調(diào)整·················陳 玥，劉 磊，高 雪，朱 曼，柴 棟（2）：63

紫杉醇（白蛋白結(jié)合型）聯(lián)合替吉奧對晚期膽管癌一線化療患者的臨床觀察研究·········································································張 娟，李 濤，秦博宇，孟憲陽，張素潔，胡 毅（2）：67

坎地沙坦預防治療偏頭痛的療效及安全性的Meta分析···············王金明，洪偉勇，申慧玲，方 芳，陳 敏（3）：132

CYP3A5基因多態(tài)性對腎病患者他克莫司臨床應用指導分析····························································李曉琳，劉 冰（3）：137

腎移植術后患者服用咪唑立賓致血尿酸升高的相關研究·············································侯文婧，溫愛萍，林 ?。?）：196

復明片聯(lián)合利拉魯肽在治療糖尿病視網(wǎng)膜病變中的應用及對患者IGF-1、VEGF水平影響······························高利娟，李月紅，李 珊，吳玲玲（4）：199

伏立康唑谷濃度在血液科患者中的分布特征及影響因素········································································張瑞霞，張 艷，張 弋，付 鵬，馮 浩（4）：204

喹硫平緩釋片治療成人精神分裂癥有效性和安全性的Meta分析········································································李 超，楊子賢，張 田，李 婷，薛 薇，譚 玲（5）：259

英夫利西單抗治療中重度銀屑病的療效及安全性研究·············齊 婧，解 方，劉卉瑩，宋翠豪，李承新（6）：325

重組人血管內(nèi)皮抑制素聯(lián)合CO2點陣激光治療瘢痕疙瘩的臨床療效觀察······························田 超，王露萍，許爾長，張?zhí)m芳（6）：328

實驗研究

Child-Pugh C級患者伏立康唑血藥濃度監(jiān)測結(jié)果分析································趙慶國，任秋霞，杜春輝，王艷紅（1）：11

HPLC法測定利咽含片中綠原酸含量···············································王歡歡，黃曉舞，白 林（1）：14

枸櫞酸鉀泡騰片的研制和質(zhì)量評價···············································孫華燕，黃曉舞，白 林（2）：71

基于冶療藥物監(jiān)測的拉莫三嗪個體化用藥分析·················周甜甜，王夏紅，張慧芝，張 穎，王 錄（2）：75

去氫駱駝蓬堿磁固體脂質(zhì)納米粒的處方和制備工藝的優(yōu)化·······························木尼熱·庫爾班，唐小慧，王 梅（3）：141

去甲萬古霉素血藥濃度檢測方法的建立及評價···············董 迪，毛 璐，宋 菲，張 威，甄健存（3）：146

刺山柑體外抗腫瘤活性提取物的篩選研究············買地哪木·色迪克，周彥霞，周曉濤，王 梅（4）：208

苦參素膠囊對小鼠急性酒精性肝損傷的影響·························································方 慧，魯長俊，呂 悅，鄭珊嬌，俞婷婷，王 寅，鄭 英（4）：212

黃硝創(chuàng)傷方抑菌有效藥味優(yōu)選研究······························張玉萌，何新榮，栗曉東，魏 靜（4）：216

反相高效液相色譜法測定老年癲癇患者血清中丙戊酸的濃度···············黃芳華，陳紅君，唐原君，朱李飛，余自成（5）：264

兩波長變化HPLC法同時測定護肝片中5 種主要成分的含量···························································唐 霄 ，張翠欣（5）：267

硝酸異山梨酯對STEMI患者心肌缺血再灌注損傷的后處理效應······························杜正強，劉 盼，梅少平，宋達琳（6）：331

重癥患者碳青霉烯類藥物血藥濃度監(jiān)測分析······························徐銀麗，郭曉芳，江翊國，梁 培（6）：335

利奈唑胺致血小板減少與二氧化碳分壓相關性分析······························王天琳，張 歡，李 晶，夏 蕾（6）：339

配伍對川芎特征圖譜的影響及指標成分含量變化研究····························································李 外，何新榮（6）：343

臨床藥師園地

對1例腎功能延遲恢復的老年患者合理使用萬古霉素的藥學監(jiān)護···············································張青霞，王 哲，閆素英（1）：17

臨床藥師對肺部感染伴房顫患者的用藥安全性監(jiān)護························································· 劉慧敏，鄭 芳，李 鵬，陳富超，李 聰，李志浩，李春雷（1）：21

1例行血漿置換的重癥腎衰竭患者聯(lián)合使用抗感染藥物的藥學監(jiān)護·················蔡 樂，雷雪梅，湯智慧，王東曉，朱 曼（2）：78

從1例INR未達標顱內(nèi)出血死亡的肺栓塞患者探討老年患者華法林的合理使用···············································張青霞，趙思邈，閆素英（2）：82

1例對多種胰島素制劑過敏的妊娠期糖尿病患者的用藥分析及藥學監(jiān)護···············································劉銀萍，董玲芳，王 艷（2）：86

1例基于萬古霉素治療藥物監(jiān)測的新生兒敗血癥藥學監(jiān)護·············································王司允，李 馨，付秀娟（3）：150

1例舌咽神經(jīng)痛合并高血壓的老年患者藥學監(jiān)護···············梁錦湄，劉智慧，朱 曼，劉靈靈，趙國利（3）：154

1例帶狀皰疹后神經(jīng)痛患者止痛治療的藥學監(jiān)護······························孫秋艷，鄧禮娟，杜 彪，陳 晨（3）：158

1例重癥肺炎合并感染性心內(nèi)膜炎患者的藥學監(jiān)護··························································向道春，程剛英，賴永繼，周 慶，劉 玨，王 奕，鄧艾平（4）：219

1例重度燒傷腸外營養(yǎng)支持治療患者血糖控制的藥學監(jiān)護····························································唐微艷，任海霞（4）：223

臨床藥師參與1 例腦梗死后出血轉(zhuǎn)化患者的藥學監(jiān)護···············向道春，周 慶，劉 玨，王 奕，鄧艾平（5）：271

一例二尖瓣機械瓣膜血栓患者的藥學監(jiān)護·············································彭文星，林 陽，張進華（5）：275

1例腹膜透析相關感染合并繼發(fā)性甲狀旁腺功能亢進患者的藥學監(jiān)護···············代瑞甫，蔡 樂，朱 曼，張艷秀，陳 勤（6）：347

1例華法林聯(lián)合卡培他濱致結(jié)腸癌患者消化道出血病例分析·············································袁曉剛，高 攀，楊彥偉（6）：351

不良反應監(jiān)測

334例兒童藥品不良反應及其超說明書用藥使用分析·················趙熙婷，宋 岐，李春曉，李學林，唐進法（1）：25

321例藥源性橫紋肌溶解癥分析······························································馬曉菲，劉星辰（1）：29

某三甲醫(yī)院2013 - 2017年兒科328例藥品不良反應回顧性分析······························································張麗麗，宋洪濤（1）：32

亞胺培南/西司他丁致成人危重癥患者中樞神經(jīng)系統(tǒng)不良反應發(fā)生情況及其危險因素分析···············································溫愛萍，李丹丹，鮑曉龍（2）：89

25例藥物過敏性休克腎上腺素救治再評價·························································褚燕琦，王之舟，劉 琛，陸 璐，曾 艷，沈江華，張青霞，閆素英（2）：93

多粘菌素B導致成人皮膚色素沉著的文獻分析······························陳 玥，買淑霞，溫欣茹，郭冬杰（3）：161

參麥注射液致過敏性休克文獻分析···············張 明，楊 洋，葉偉軍，謝法紅，辛海莉（3）：165

沙庫巴曲纈沙坦致不良反應的文獻分析···············徐 虹，梁月琴，夏洪穎，王 麗，李仲昆（4）：227

術中快速靜脈滴注萬古霉素致嚴重低血壓的文獻分析并實例探討···············沈江華，于雅卉，褚燕琦，胡海量，孔 超（4）：231

399例蛇毒類血凝酶相關藥品不良反應報告分析及風險信號挖掘··························································齊 榛，郭代紅，姚 翀，楊鴻溢，龐 寧，劉思源，栗嘯陽（5）：278

沙庫巴曲纈沙坦致不良反應的文獻分析······························宋兆芮，王相峰，宋燕青，李艷嬌（5）：283

莫西沙星致不良反應134 例文獻分析·············································肖丹丹，趙廣闊，陳 敏（5）：287

重組人血管內(nèi)皮抑制素（恩度）聯(lián)合化療的不良反應自動監(jiān)測研究···············王東曉，賴輝莉，郭代紅，朱 曼，姚 翀（5）：292

4760例阿司匹林腸溶片不良反應報告分析·············································王 薇，陳興莉，吳世福（6）：354

磷酸奧司他韋致33例不良反應病例分析·············································劉 洋，夏彬彬，成 華（6）：357

藥物利用分析

602例住院患者華法林臨床應用分析·············································· 蘭艷纖，馮 茜，韋美丹（1）：36

我院糖尿病并發(fā)感染患者抗菌藥物應用分析····························································· 常 偉，唐扣明（1）：39

2013 - 2017年中國七城市95家醫(yī)院降膽固醇藥物用藥分析································方振威，石秀錦，石 佳，林 陽（2）：96

血必凈注射液不合理用藥情況分析·············································崔海珍，于 倩，王 華（2）：100

我院肝病患者輔助用藥藥學干預效果評價·············································趙慶國，朱 紅，張曉云（2）：104

我院老年糖尿病住院患者降低心血管風險藥物使用情況分析······························蔡 俊，韓 丹，聶 力，李 曼（3）：168

108例老年患者抗感染藥物用藥錯誤報告分析····························································計紫超，王 昕（3）：172

我院實施干預前后輔助用藥重點監(jiān)控品種使用合理性分析··························································李 冬，胡 輝，劉麗霞，郭 靜，李名慧，張 瑞，郭婷婷，伊麗努爾（4）：235

國內(nèi)神經(jīng)外科兒童顱內(nèi)感染現(xiàn)狀分析···············陳 玥，李 婷，劉 磊，朱 曼，柴 棟（4）：239

我院腫瘤患者出院帶抗腫瘤藥物情況及風險分析···············范倩倩，常 青，朱 珠，楊根治，史亦麗（5）：297

我院2018 年度門診不合理抗菌藥物處方的帕累托法分析··························································曹 暢，劉岳金，曾玉蘭，鐘凱龍，王路敏，曾娜婷，葉巖榮（5）：302

101例替加環(huán)素臨床應用調(diào)查分析······························章 曄，何冰冰，王咪咪，王 敏（5）：305

我院2014 - 2018年腸外腸內(nèi)營養(yǎng)藥品應用分析········································周 鵬，李珂佳，和 潔（6）：361

我院外科預防使用質(zhì)子泵抑制劑的干預效果分析·············································陳 婧，王 明，尹東鋒（6）：365

2014 - 2018年我國七城市DPP-4抑制劑使用現(xiàn)狀調(diào)查···············周 洋，石秀錦，彭文星，魏娟娟，林 陽（6）：369

藥學服務

三種老年人潛在不適當用藥評估標準的比較···············································張彩霞，馬 卓，崔向麗（1）：43

美法兩國對超說明書用藥監(jiān)管對策及其借鑒啟示······························································郭俊榮，張 方（1）：46

臨床藥師干預對呼吸內(nèi)科藥物使用及住院醫(yī)囑的效果評價·············································馬 靜，崔立慧，湯守香（2）：108

藥學進展

PD-1/PD-L1抑制劑治療EGFR突變非小細胞肺癌的研究進展······························智曉玉，王少偉，宋 琪，汪進良（6）：373

案例分析

藥物超敏綜合征1例并文獻回顧································齊 婧，解 方，郝 甜，李承新（1）：50

哌拉西林鈉他唑巴坦鈉致Stevens-Johnson綜合征1例·················任 林，宋惠珠，王祥衛(wèi)，黃曉娜，蔡小軍（1）：54

1例長期應用阿德福韋酯致范可尼綜合征的案例分析······························································劉成克，黃翠麗（1）：57

美托洛爾干預Brugada綜合征合并高血壓1例···············································張哲鵬，單冠男，段利平（1）：60

復方甘草酸苷致低血鉀與橫紋肌溶解1例并文獻分析······························李洪英，李漢高，丁傳華，張在麗（2）：112

1例吉西他濱對華法林抗凝作用影響的案例分析····························································朱孔彩，薛文瑞（2）：116

1例帕博利珠單抗致免疫相關性肺炎的病例分析····························································楊彥偉，王偉蘭（2）：119

注射用亞胺培南西司他丁鈉致頑固性呃逆1例···········································································李 琳（2）：122

紫杉醇聯(lián)合順鉑化療致膽汁淤積性藥物性肝損傷1例······························邱 剛，蘇穎杰，王萌萌，嚴頤丹（2）：124

乙酰半胱氨酸致咯血1例·············································湯守香，李素娟，馬 靜（3）：176

氯吡格雷和瑞格列奈相互作用致低血糖1例·············································駱海坤，王麗華，郝利亞（3）：178

伐昔洛韋片致血液透析患者腦病1例·············································王冬雪，徐 鋒，侯繼秋（3）：181

阿莫西林四聯(lián)療法致重癥多形紅斑藥疹1例······························孫文芳，王慧英，張曉蘭，劉憲軍（3）：183

活力蘇口服液致重度肝損傷2例····························································董 清，屠建華（3）：186

甲潑尼龍琥珀酸鈉致連續(xù)噴射性嘔吐1例···············辛秀琴，王冬雪，李 立，侯繼秋，張 秀（3）：189

甲潑尼龍聯(lián)用伏立康唑致類固醇肌病2例··························································徐德鐸，盧江燕，潘 玨，胡必杰，呂遷洲，陳萬生，陳璋璋（4）：243

伏立康唑致幻覺1例······························雷 露，喬 逸，楊志福，文愛東（4）：246

破傷風人免疫球蛋白致全身皮疹1例并文獻分析······························謝法紅，李淵源，聶 帥，辛海莉（4）：248

復方甘草酸單銨S致高血壓1例··························································王金明，申昌龍，董德強，魏 靜，周雪峰，夏修遠，曹明雪（4）：251

萬古霉素致患兒發(fā)熱性中性粒細胞減少案例分析···············程剛英，馬 釗，姜 茜，周 慶，鄧艾平（4）：253

PD-L1抗體Atezolizumab致多臟器免疫相關不良反應1例·············································黃榕彬，徐 萍，劉文輝（4）：256

伏立康唑致視覺障礙1 例·········································································王金明，洪偉勇，申昌龍，董德強，魏 靜，曹明雪（5）：309

鹽酸胺碘酮注射液致急性過敏2 例·············································李艷嬌，王相峰，張文銳（5）：311

利拉魯肽致心率增快1 例·············································湯智慧，黃克圍，裴 育（5）：314

慢性腎臟病患者骨質(zhì)疏松治療期間發(fā)生高鈣血癥致急性腎損傷1 例·············································宋 堯，溫愛萍，郭 王（5）：317

糖皮質(zhì)激素沖擊致腎功能不全患者抽搐·············································王冬雪，吳淋淋，侯繼秋（5）：320

嗎啡注射液致短暫性肌無力1 例·············································尹 航，于 倩，邵 丹（5）：322

臨床藥師參與1例T-DM1致血小板Ⅳ度降低及其治療的案例分析·············································祁巧玲，俞 平，房文通（6）：377

頭孢哌酮鈉/舒巴坦鈉靜脈輸注致凝血功能障礙1例··························斯日古楞，郭小彬，烏日汗，楊宏昕（6）：380

哌拉西林鈉/舒巴坦鈉致繼發(fā)性血小板增多癥伴遲發(fā)型皮疹1例·············································于雅卉，沈江華，褚燕琦（6）：383

信 息

《中國藥物應用與監(jiān)測》雜志2019年征訂啟事 ···········（1）：28

中國研究型醫(yī)院學會藥物評價專業(yè)委員會第二屆全國臨床用藥風險監(jiān)測與防控學術研討會征文通知················（1）：62

《中國藥物應用與監(jiān)測》稿約 ········································（1）：Ⅰ

《中國藥物應用與監(jiān)測》雜志2019年征訂啟事 ···········（2）：70

《中國藥物應用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·························································································（2）：74

案例分析欄目介紹·························································（2）：95

臨床評價欄目介紹·······················································（2）：103

臨床藥師園地欄目介紹···············································（2）：107

《中國藥物應用與監(jiān)測》雜志2019年征訂啟事 ········（3）：136

臨床藥師園地欄目介紹···············································（3）：145

臨床評價欄目介紹·······················································（3）：149

《中國藥物應用與監(jiān)測》雜志關于投稿的聲明 ··········（3）：157

《中國藥物應用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·······················································································（3）：171

案例分析欄目介紹·······················································（3）：180

臨床評價欄目介紹·······················································（4）：207

《中國藥物應用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·······················································································（4）：211

《中國藥物應用與監(jiān)測》雜志2019年征訂啟事 ·········（4）：226

臨床藥師園地欄目介紹···············································（4）：230

案例分析欄目介紹·······················································（4）：242

《中國藥物應用與監(jiān)測》雜志關于投稿的聲明 ··········（4）：255

《中國藥物應用與監(jiān)測》雜志關于投稿的聲明 ··········（5）：270

《中國藥物應用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·······················································································（5）：274

《中國藥物應用與監(jiān)測》雜志2020 年征訂啟事 ·········（5）：319

《中國藥物應用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·······················································································（6）：334

臨床藥師園地欄目介紹···············································（6）：353

案例分析欄目介紹·······················································（6）：379

《中國藥物應用與監(jiān)測》雜志2020 年征訂啟事 ·········（6）：385